Detalhe da pesquisa
1.
Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless Study.
J Infect Dis
; 226(2): 308-318, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351072
2.
Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America.
Clin Infect Dis
; 73(6): 1003-1012, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822015
3.
Estimating the annual dengue force of infection from the age of reporting primary infections across urban centres in endemic countries.
BMC Med
; 19(1): 217, 2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587957
4.
A serological framework to investigate acute primary and post-primary dengue cases reporting across the Philippines.
BMC Med
; 18(1): 364, 2020 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33243267
5.
Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.
J Infect Dis
; 217(4): 567-571, 2018 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325161
6.
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.
N Engl J Med
; 373(13): 1195-206, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26214039
7.
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.
Lancet
; 384(9951): 1358-65, 2014 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25018116
8.
Factors influencing healthcare utilization among children with pneumonia in Muntinlupa City, the Philippines.
Southeast Asian J Trop Med Public Health
; 45(3): 727-35, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24974657
9.
Proceedings of the 6th Asia Dengue Summit, June 2023.
PLoS Negl Trop Dis
; 18(3): e0012060, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551892
10.
Proceedings of the 5th Asia Dengue Summit.
Trop Med Infect Dis
; 8(4)2023 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104356
11.
Immunogenicity and Safety of a Newly Developed Live Attenuated Varicella Vaccine in Healthy Children: A Multi-National, Randomized, Double-Blinded, Active-Controlled, Phase 3 Study.
Vaccines (Basel)
; 11(9)2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766093
12.
Safety, efficacy, and impact on gut microbial ecology of a Bifidobacterium longum subspecies infantis LMG11588 supplementation in healthy term infants: a randomized, double-blind, controlled trial in the Philippines.
Front Nutr
; 10: 1319873, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38162520
13.
Safety of primary immunization with a DTwP-HBV/Hib vaccine in healthy infants: a prospective, open-label, interventional, phase IV clinical study.
Expert Rev Vaccines
; 21(5): 685-692, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220869
14.
Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9-50 years: a randomised, controlled, phase 2, non-inferiority study.
Lancet Infect Dis
; 22(6): 901-911, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35364022
15.
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose.
NPJ Vaccines
; 7(1): 12, 2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35087084
16.
Assessing the burden of dengue among household members in Alaminos, Laguna, the Philippines: a prospective cohort study.
Asian Biomed (Res Rev News)
; 15(5): 213-222, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37551324
17.
A Narrative Review of Pneumococcal Disease in Children in the Philippines.
Infect Dis Ther
; 10(2): 699-718, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895977
18.
Serological Evidence of Widespread Zika Transmission across the Philippines.
Viruses
; 13(8)2021 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452307
19.
Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study.
Lancet Infect Dis
; 21(4): 517-528, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33212067
20.
Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9-12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial.
Vaccine X
; 6: 100074, 2020 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33005887